Ventricular Assist Devices Market Forecast 2019 with Abbott, Abiomed, Berlin Heart Inc, BiVACOR Inc, CardiacAssist, Inc., Evaheart, Inc., Maquet Getinge Group, Medtronic, Terumo Medical Corporation
U.S. dominated the North America ventricular assist devices market and was valued at around USD 615.1 million in the year 2017. According to Center for Disease Control and Prevention (CDC), around 610,000 people die of heart disease in the U.S. every year. Increase in number of people suffering from cardiovascular disease, recent technological advancements and favorable reimbursement policies in the country will boost the demand and adoption rate of ventricular assist devices, augmenting the market growth in United States.
Increase in number of people suffering from heart failure and other cardiovascular diseases in European countries will be one of the major impact rendering factors for the growth of ventricular assist devices market in the forthcoming years. As per the statistics published by the European Heart Network, every year around 4 million people in Europe and over 2 million in Europe Union (EU) die because of several cardiovascular diseases. Increase in patients suffering from cardiovascular diseases leading to heart failure will lead to growing demand and adoption rate of ventricular assist devices, fueling the industry growth.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/3014
Technological advancements in the North America region has resulted in ventricular assist devices becoming an increasingly widespread and accepted therapy for patients suffering from high heart failure rate. Technological advances have led to improved durability of the devices’ implantability, extended support and also lengthened the survival rates in patients. Introduction of latest third generation left ventricular assist device employs magnetic levitation (MAGLEV) technology that allows rotation without wear and friction. Hence, growing technological advancements pertaining to ventricular assist devices in North America will boost the market growth.
High cost of the devices and the implantation procedures will be one of the major factors impeding the growth of the market. The ventricular assist device on an average costs around USD 100,000 and the total procedure costs around USD 700,000 over a six year period. The high cost of the device and procedures is unaffordable to the low and middle income patient population, thereby declining the demand and growth of the business.
Left ventricular assist devices market held the majority of market share in the year 2017 and was valued over USD 829.9 million. Increase in number of people suffering from end-stage heart failure will result in growing demand and adoption rate for LVAD devices, enhancing the left ventricular assist devices market growth in the near future.
Browse Full Report Details @ https://www.gminsights.com/industry-analysis/ventricular-assist-devices-market
Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
Berlin Heart Inc
Maquet Getinge Group
Medtronic, Terumo Medical Corporation
Right ventricular assist devices market is estimated to grow at a robust CAGR of 10.6% in the forthcoming years. Increase in number of people suffering from acute right ventricular failure will result in boosting the demand and adoption rate, thereby augmenting business growth in the near future.
Bridge-to-candidacy (BTC) therapy market held the maximum market share an was valued around at USD 316.4 million in the year 2017. Decrease in number of heart donors across the globe has resulted in people opting for ventricular assist devices, but the patients that are not listed for transplantation are provided BTC therapy. Increase in use of BTC therapy for severe heart failure patients needing ventricular assist device implantation urgently will enhance the market growth in the near future.
Destination therapy market is projected to witness considerable amount of growth at a CAGR of 10.8% during the forecast time period. Destination therapy provides long-term support to the patients and is one of the most advised therapies in the treatment of severe end-stage heart failure amongst the population. Several benefits provided such as high survival rate, better quality of life, cost-effectiveness and cost utility will be one of the major reasons for boosting the growth of ventricular assist devices market for destination therapy.
The sales of ventricular assist devices among people aged between 60-79 years was high and was valued at around USD 444.0 million in the year 2017. According to a recent research survey, it was observed that the chances of heart failure are high, and prevalence of cardiovascular diseases is around 70% to 75% in people of 0-79 years of age. Increase in geriatric population across the globe will result in growing number of people prone to cardiovascular diseases, fuelling the growth of ventricular assist devices in the future.
The sales of the ventricular assist devices among people aged between 40-59 years is estimated to grow significantly at a CAGR of 10.6% over the forecast timeframe. As per the research studies, the prevalence of cardiovascular diseases among people aged between 40-59 years is around 40% but, growing sedentary lifestyle, smoking, alcohol consumption and improper eating habits is expected to increase the prevalence. Growing prevalence of cardiovascular disease in people aged between 40-59 years will boost the sales of ventricular assist devices.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/3014
India ventricular assist devices market is estimated to grow substantially at a CAGR of 15.2% during the projection period. Growing geriatric population in the Asia Pacific region will result in high cardiovascular disease prevalence leading to high heart failure rates. Also, rise in awareness among the patients about the treatments related to cardiovascular diseases and heart failure will increase the demand for ventricular assist devices in the country.
About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Corporate Sales, USA
Global Market Insights, Inc.
Toll Free: 1-888-689-0688
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ventricular Assist Devices Market Forecast 2019 with Abbott, Abiomed, Berlin Heart Inc, BiVACOR Inc, CardiacAssist, Inc., Evaheart, Inc., Maquet Getinge Group, Medtronic, Terumo Medical Corporation here
News-ID: 1542958 • Views: 204
More Releases from Global Market Insights, Inc
How global Crane Market Growing Rapidly...? Top players - Liebherr Group, Terex …
The Crane Market research study is a detailed document that presents a gist of the global industry space in terms of numerous parameters. Some of these falls along the likes of the industry insights, growth drivers, industry segmentation, size and trends worldwide. Crane Market is expected to exceed USD 28 billion by 2025. The increasing construction spending and the emergence of new public & private infrastructures across the globe
Global Hydraulic Hoist Market 2019 by regional trend & growth forecast to 2025 | …
Global Market Insights has recently added Hydraulic Hoist Market report which mentions valuable insights pertaining to market share, profitability graph, market size, SWOT analysis, and regional proliferation of this industry. The Asia Pacific regional Hydraulic Hoist Market is predicted to have the lion's share, in the entire forecast period. This regional market might cross USD 140.0 million till 2025, at CAGR more than 5.9%. The North America
Pharmacovigilance Outsourcing Market Growth Analysis by Product, Application, In …
U.S. pharmacovigilance outsourcing market dominated North America region and was valued at USD 783.2 million revenue in 2017 and is estimated to witness similar trend during the forthcoming years. The high growth is attributed to strong foothold of major pharma and medical device companies coupled with extensive drug development activities in the U.S. Moreover, high healthcare expenditure in the country and growing concern regarding drug safety and adverse drug reactions
United Rentals | Construction Equipment Rental Market 2024 | Top Manufacturers U …
Construction Equipment Rental Market in Asia Pacific is expected to reach over USD 40 billion by 2024. The emerging trend of the organizations toward renting of heavy construction equipment will have a positive impact toward the industry demand. Rising wage rates in China coupled with the changing consumption patterns are generating a huge demand for the rental machinery. Construction Equipment Rental Market to cross $140 billion by 2024.
More Releases for Increase
How to Increase Student Productivity
In a world where today's students have access to so many technological advancements – ranging from computer word-processors to instant access to online reference materials – the rate of student productivity and scholastic achievement hasn't kept pace. What can be done about it? Equipped with a tablet and access to the Internet, today's students have instant access to the treasure trove of the world's information. Yet, given all these new technology
Pigs‘ Toys Increase Animal Wellbeing
Less Injuries in Pig Houses In cooperation with Kassel University, WEDA Dammann & Westerkamp, specialists for pig house equipment from Lutten, have developed a new kind of manipulable material for piglets and fattening pigs. By means of the rooting cones and pushing balls of bite-resistant and food-safe polyurethane, mounted to floor and brackets, the animals can act out their natural play instinct and can permanently busy themselves while standing up, sitting,
Increase in the ‘Staycation’
The new ‘buzz’ word ‘staycation’ as it is known, has become increasingly popular, with the cost of family holidays abroad on the increase, and the value of the pound weaker, families are choosing to holiday in the UK. Camping and caravanning in the UK is at the top of the list for a brilliant ‘staycation’. As the cut-backs start to take effect and everyone is feeling the pinch in their
PROPOSAL CAPITAL INCREASE
The Board of Directors of EXMAR has decided to propose to the shareholders to proceed with a capital increase of EUR 100 million. Saverex NV, the reference shareholder of EXMAR, will participate in the capital increase with an amount of EUR 50 million. Sofina SA will also participate in the transaction in accordance with its current shareholding in the company (approx. 1.3%). Sofina SA has confirmed a further support to
Oxea Announces DOP Price Increase
Oberhausen, February 6, 2009 – Oxea will increase list and off-list prices on the product below effective February 9th, 2009, or as contracts allow. Europe: DOP 25 €/mt Oxea is a global supplier of solvents, polyols and oxo derivatives such as Carboxylic acids, Esters and Amines. These products are used for the production of high-quality coatings, lubricants, cosmetic and pharmaceutical products, flavorings and fragrances, printing inks and plastics. The company is
HUGO BOSS proposes dividend increase
Metzingen, March 11, 2008. After a successful close to fiscal 2007 and based on a positive assessment of the Company´s continued performance, the Supervisory and Managing Boards of HUGO BOSS AG have decided to propose to the Annual Shareholders´ Meeting to increase dividends by EUR 0.26 to EUR 1.45 (2006: EUR 1.19) per common share and EUR 1.46 (2006: EUR 1.20) per preferred share. The Supervisory Board also gave consideration